DESNT: A Poor Prognosis Category of Human Prostate Cancer
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in European Urology Focus
- Vol. 4 (6) , 842-850
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical ProstatectomyPLOS ONE, 2013
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and ContextJNCI: Journal of the National Cancer Institute, 2009
- Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST ArraysThe Journal of Molecular Diagnostics, 2008
- Complex patterns of ETS gene alteration arise during cancer development in the human prostateOncogene, 2007
- Identification of prognostic signatures in breast cancer microarray data using Bayesian techniquesJournal of The Royal Society Interface, 2005
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002